ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
0,676
0,00
(0,00%)
Geschlossen 19 November 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,676
Gebot
0,6601
Fragen
0,676
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
0,676
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

VICL Neueste Nachrichten

Vical Stockholders Approve Reverse Stock Split and Merger with Brickell

•  Merger Transaction Expected to Close August 31, 2019 SAN DIEGO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (“Vical”) (Nasdaq:VICL) announced that its stockholders voted to approve...

Moore Kuehn, PLLC Encourages Vical Incorporated (VICL), ASV Holdings, Inc. (ASV), PCM, Inc. (PCMI), WageWorks, Inc. (WAGE), a...

Moore Kuehn, PLLC Encourages Vical Incorporated (VICL), ASV Holdings, Inc. (ASV), PCM, Inc. (PCMI), WageWorks, Inc. (WAGE), and Acacia Communications, Inc. (ACIA) Investors to Contact Firm PR...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Vical Incorporated Acquisition

SHAREHOLDER ALERT: WeissLaw LLP Investigates Vical Incorporated Acquisition PR Newswire NEW YORK, June 12, 2019 NEW YORK, June 12, 2019 /PRNewswire/ -- WeissLaw LLP  is investigating possible...

Vical and Brickell Announce Merger Agreement

Combined Company Well-Capitalized with Approximately $35 Million in Cash and up to $25 Million in Near-Term R&D FundingPivotal Phase 3 Clinical Trials for Brickell’s Lead Product Candidate...

Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives

SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that it has decided to discontinue the Phase 2 clinical trial of VL‑2397 that was initiated in the...

Vical Reports Third Quarter 2018 Financial and Operational Results

SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months ended September 30, 2018. Net loss for the third quarter of...

Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...

Vical Reports Second Quarter 2018 Financial and Operational Results

SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months ended June 30, 2018. Net loss for the second quarter of 2018...

Vical Announces Review of Potential Strategic Transactions

SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that its Board of Directors plans to explore a range of strategic options to enhance shareholder...

Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint

SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced top-line results from a randomized, double-blind, placebo-controlled, Phase 2 clinical study of its...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
HCWBHCW Biologics Inc
US$ 1,235
(319,21%)
511,7M
APLMApollomics Inc
US$ 0,1922
(100,42%)
1,68B
SINTSiNtx Technologies Inc
US$ 3,18
(55,88%)
52,01M
ACRSAclaris Therapeutics Inc
US$ 3,16
(54,15%)
30,65M
JWELJowell Global Ltd
US$ 2,8358
(45,43%)
15,45M
QMMMQMMM Holdings Limited
US$ 1,73
(-76,40%)
6,14M
CMAXCareMax Inc
US$ 0,87
(-48,21%)
838,95k
NGNENeurogene Inc
US$ 19,82
(-42,58%)
2M
DWTXDogwood Therapeutics Inc
US$ 1,85
(-37,71%)
143,85k
SGDSafe and Green Development Corporation
US$ 1,68
(-36,84%)
489,76k
APLMApollomics Inc
US$ 0,1922
(100,42%)
1,68B
HCWBHCW Biologics Inc
US$ 1,235
(319,21%)
511,7M
ELABElevai Labs Inc
US$ 0,0225
(1,81%)
290,23M
NVDANVIDIA Corporation
US$ 140,15
(-1,29%)
222,24M
SMCISuper Micro Computer Inc
US$ 21,54
(15,93%)
198,08M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock